Gans R O, Kuizinga M C, Goldschmeding R, Assmann K, Huysmans F T, Gerlag P G, Donker A J, Hoorntje S J
Department of Medicine, Free University Hospital, Amsterdam, The Netherlands.
Nephron. 1993;64(2):182-8. doi: 10.1159/000187311.
We investigated the clinical features and outcome of 60 patients with antineutrophil cytoplasmic autoantibodies with cytoplasmic staining (C-ANCA)- and with (peri)nuclear staining (P-ANCA)-associated glomerulonephritis. Virtually all patients with C-ANCA had antibodies against proteinase 3, which corresponded with a clinical and/or histological diagnosis of Wegener's granulomatosis (WG). P-ANCA were associated with antibodies against myeloperoxidase. Although more often associated with renal-limited disease, a significant number of patients with P-ANCA had also symptoms of organs known to be preferentially affected with WG. The majority of patients presented with rapidly progressive glomerulonephritis which responded favorably to immunosuppressive therapy, albeit at the expense of a considerable number of fatal infections. Furthermore, a more protracted form of glomerulonephritis was recognized. A kidney biopsy scoring system appeared to be of value in predicting which patients would benefit most from treatment. C-ANCA and P-ANCA appear to identify a subset of patients with vasculitis that share common clinical features and a favorable response to immunosuppressive therapy.
我们调查了60例抗中性粒细胞胞浆抗体呈胞浆染色(C-ANCA)和(周)核染色(P-ANCA)相关肾小球肾炎患者的临床特征及预后。几乎所有C-ANCA阳性患者均有抗蛋白酶3抗体,这与韦格纳肉芽肿病(WG)的临床和/或组织学诊断相符。P-ANCA与抗髓过氧化物酶抗体相关。尽管P-ANCA更多与肾脏局限性疾病相关,但相当数量的P-ANCA阳性患者也有已知WG优先累及器官的症状。大多数患者表现为快速进展性肾小球肾炎,对免疫抑制治疗反应良好,尽管代价是有相当数量的致命感染。此外,还认识到一种病程更长的肾小球肾炎形式。肾脏活检评分系统似乎对预测哪些患者将从治疗中获益最大有价值。C-ANCA和P-ANCA似乎可识别出一组具有共同临床特征且对免疫抑制治疗反应良好的血管炎患者。